Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ted L. Underiner"'
Autor:
Deborah Galinis, Sheila J. Miknyoczki, Ted L. Underiner, Damaris Rolon-Steele, Jean Husten, Craig A. Zificsak, Thelma S. Angeles, Torsten Herbertz, Mark S. Albom, Bruce D. Dorsey, Laura S. Kocsis, Kevin J. Wells-Knecht, Jay P. Theroff, Lisa D. Aimone, Kelli S. Zeigler, Candace S. Worrell, Rebecca A. Brown, Christine LoSardo, Seetha Murthy, Jennifer Grobelny
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:660-663
Elaboration of the SAR around a series of 2,4-diaminopyrimidines led to a number of c-Met inhibitors in which kinase selectivity was modulated by substituents appended on the C4-aminobenzamide ring and the nature of the C2-aminoaryl ring. Further lea
Autor:
Linda Weinberg, Ted L. Underiner, Mark S. Albom, Craig A. Zificsak, Arup K. Ghose, Renee C. Roemmele, Mangeng Cheng, Karen L. Milkiewicz, Jay P. Theroff, Bruce D. Dorsey, Thelma S. Angeles
Publikováno v:
Bioorganic & Medicinal Chemistry. 18:4351-4362
Dysregulation of the anaplastic lymphoma kinase (ALK) is implicated in a variety of cancers. A series of tetrahydropyrido[2,3-b]pyrazines was constructed as ring-constrained analogs of a known aminopyridine kinase scaffold. Chemistry was developed to
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 10:7-27
The scatter factor/hepatocyte growth factor (HGF)-c-Met axis is involved in the malignant phenotype of various tumor types via activation of a wide range of autocrine and paracrine processes. Autocrine activation of tumor cell c-Met receptors enhance
Autor:
Edward R. Bacon, Robert L. Hudkins, Thelma S. Angeles, Jennifer Grobelny, Mark S. Albom, Reddeppareddy Dandu, Bruce Ruggeri, Sheila J. Miknyoczki, Lisa D. Aimone, Shi Yang, Candy Robinson, Hong Chang, Allison L. Zulli, Ted L. Underiner
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:1916-1921
Fused dihydroindazolopyrrolocarbazole oximes have been identified as low nanomolar, potent dual TIE-2 and VEGF-R2 receptor tyrosine kinase inhibitors with excellent cellular potency. Development of the structure-activity relationships (SAR) led to id
Autor:
Ursula Mocek, Ted L. Underiner, Sheldon E. Broedel, Gail E. McElhaney-Feser, Robert E. Raulli, Jodi A. Laakso, Paul Actor, Brian J. Hotovec, Ronald L. Cihlar
Publikováno v:
Journal of Natural Products. 66:1041-1046
A systematic screen for new natural products that displayed antifungal activity by inhibition of fungal fatty acid synthase (FAS) led to the discovery of two new fungal metabolites, designated CT2108A (1) and CT2108B (2). The metabolites were produce
Autor:
Richard D. Cramer, Allan M. Ferguson, Ted L. Underiner, Cheryl D. Garr, Michael S. Lawless, Lauri Schultz, John R. Peterson, David E. Patterson, Amy Oliver
Publikováno v:
SLAS Discovery. 1:179-186
By integrating advanced computational design and synthesis, a series of structurally diverse reaction products based on three core scaffolds were prepared by a propietary high throughput synthesis method. Incorporation of auto-mated work stations and
Publikováno v:
SLAS Discovery. 1:65-73
The selection of compounds for use in high throughput biological assays is one of the critical factors that dictates the likelihood of detecting exploitable biological properties. In this paper, we present a process designed to deliver molecules that
Autor:
Ted L. Underiner, Sheryl L. Meyer, Beverly P. Holskin, Thelma S. Angeles, Jay P. Theroff, Jie Qian
Publikováno v:
Assay and drug development technologies. 10(4)
Heat shock protein-90 (HSP90) is an ATP-dependent molecular chaperone with intrinsic ATPase activity. HSP90 is required for the stability and function of client proteins, many of which are involved in oncogenesis. Thus, identification of HSP90 inhibi
Autor:
Nadine C. Becknell, Thelma S. Angeles, Edward R. Bacon, Hugh Zhao, Lisa D. Aimone, Sheila J. Miknyoczki, John P. Mallamo, Susan Jones-Bolin, Mark S. Albom, Hong Chang, Robert L. Hudkins, Allison L. Zulli, Mark A. Ator, Bruce Ruggeri, Kathryn Hunter, Ted L. Underiner
Publikováno v:
Journal of medicinal chemistry. 55(2)
A substantial body of evidence supports the utility of antiangiogenesis inhibitors as a strategy to block or attenuate tumor-induced angiogenesis and inhibition of primary and metastatic tumor growth in a variety of solid and hematopoietic tumors. Gi
Autor:
Henry J. Breslin, James P. Finn, Lisa Saville, Jennifer L. Mason, Ted L. Underiner, Derek Dunn, Linda Weinberg, Jean Husten, Mahfuza Jan, Jay P. Theroff, Thelma S. Angeles, Teresa M. O'Kane, Karen L. Milkiewicz, Diane E. Gingrich, Tho V. Thieu, Lisa D. Aimone, Mark S. Albom, Craig A. Zificsak, Bruce D. Dorsey, Pawel Dobrzanski
Publikováno v:
Bioorganicmedicinal chemistry letters. 22(1)
The elaboration of a novel scaffold for the inhibition of JAK2 and FAK kinases was targeted in order to provide a dual inhibitor that could target divergent pathways for tumor cell progression.